Every long acting beta agonist has this on the label. Including those for the treatment of asthma. These are maintenance therapies for reactive airway disease. Not to be used for rescue. Albuterol is te short acting rescue inhaler. If you use this or any other long acting beta agonist, you decrease the effectiveness of albuterol in a rescue setting, which could lead to death. It's a blanket statement on any inhaler with a long acting beta agonist component
His reputation as a what? A reporter? A political science major? He likes to find little inaccuracies, and blows them up out of good proportions so his minions can get shares of good companies at a 20% discount.
The companies he "exposes" and that eventually fail are companies that you shouldn't be investing anyway, and it doesn't take a poly sci major to find problems with the studies done by those companies (CLSN). Lol.
Was just about to post this. But they already gave out a positive opinion two weeks ago. I think it is being discussed today at the committee. I wonder if the surprise approval by the FDA will play into their decision at all.
Ok, so you shorted at $19 a share. You had the opportunity to close it out at $2 a share, but you inexplicably didn't close out. This stock will NEVER hit $2 a share again. You could have made the most bang for your buck then. What are you waiting for turd? You are losing money every day you wait. You don't make any sense. I am a dermatologist. See my posts on other boards, but you still won't believe me. I bought 10,000 shares because my oncologist friend said that this was bargain basement (I picked up at $5 a share, so I missed on some profit). Did you wonder how 125 million shares changed hands on Friday? Its people like my oncologist friend (in the know), me, and the hundreds of other people who bought in because their oncologist friends told them the company is going back up.
He is not concerned about the heart/clotting issues. Patients with CML, have 4-20x more white blood cells in their blood to begin with. That makes your blood THICK. Patients with CML (and acute crisis patients) should be on DVT and clot prophylaxis anyway. If they have a-fib, they should be on warfarin to prevent clots to the brain. Oncologists are still going to prescribe this because it is the only medicine left for many patients with CML.
Don't kid yourself. If you are short, you are losing money each day you don't cover (regardless of if you are in the green or in the red right now).
I don't pity you for your stubborness. You had every chance to get out, but what? You were waiting for it to drop to $0? Well sorry that didn't happen. Now run along, and stop posting incessantly on this message board. Its a lose lose for you.
That is all
Jonas, Iclusig did lose some patients, temporarily, so these numbers are a little high for right now. In about two years, when the trials show the full extent of Iclusig's potential, we will be at Chardan's rating ~$28. Not bad, from $6.50 to ~$28... I can't ask for anything more from an investment.
Sounds like an alias from so many boards. One of his aliases is antiquoll on NBS message board and then a number. It was antiquoll22 for a while, but The number changes because he gets kicked off and reported for making dumb comments. When a stock is above $6.66 and he wants to bash it an short it he makes devil comments and bashes the management. Then when the company is on an uptick, he says 7.77 or he just stops posting. All into these dumb numbers
Not better. The other ones have been out longer. Gleevec is the gold standard first in class targeted therapy for any disease, then two drugs came after that. None target the gatekeeper mutation, which is how CML cells gain resistance to bcr-abl active drugs. Only Iclusig can do that. That's why their will always be a niche for this drug
Random people acting like longs saying they're scared.
Random low price targets.
Lies about the overseas market which is still closed because Europeans love they-selves some Kristmas
Wow, they are gonna lose money if they short. They may be right about today, who knows. But my opinion is they try to take it down to 7, it might even hit 6.80 but its gonna bounce up like Rocky against Drago, and if they don't cover, their gonna lose their shorts, and their Dodge Stratus. Because you know they drive a Dodge Stratus!!!
Jake, I am on your side. I picked up another 60,000 shares today at 0.0610, but you do realize MANF is not an early detection marker, but in fact a cytoprotective factor that AMBS is trying to use as a treatment for several diseases.
Lympro and NeuroPro are the diagnosistics.
I too am very optimistic. But not so cautious anymore. When the company didn't have any money I was more cautious.
I've been laying low (been crushed at work). Bashers just make me too mad, so I mostly just search for people's comments that I enjoy reading (the banter between Risk and Watson/Coldcoffee, etc. I went in big on ARIA, added more here, and INO, of course. Those are my big 3 for 2014. CYTR and NVIV are now on the watch list as well with small feelers out. Happy Holidays to you and yours